Korean J Asthma Allergy Clin Immunol.
2012 Jun;32(2):67-72.
Leukotrienes and Allergic Inflammation
Abstract
- Leukotrienes (LTs) are important lipid mediators involved in allergic inflammation. The LT pathway is relatively steroid-resistant, which suggests the possibility that its blockade by alternative means may facilitate asthma management. Cysteinyl LT receptor 1 antagonists are well accepted for their efficacy and safety in asthma management. Recent studies have revealed evolving findings indicating that leukotriene B4 has an important role in the development of asthma as well as in the potential importance of cysteinyl LTs in airway remodeling. These new findings provide important clues to achieve superior control of allergic inflammation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Mast Cells and Allergic Rhinitis
- Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
- Treatment of Allergic Rhinitis
- Effects of Eupatilin on the Release of Leukotriene B4 , by Helicobacter pylori - stimulated Neutrophils and Gastric Mucosal Cells
- Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
